Usana Health Sciences (USNA) EPS (Weighted Average and Diluted) (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.41 in Q2 2026.

• EPS (Weighted Average and Diluted) for Q2 2026 came in at $0.41, down 16.33% year-over-year; the trailing twelve-month figure through Apr 2026 was $0.48 (down 73.63% YoY), and the FY2026 annual result was $0.58, down 73.52% from the prior year.
• EPS (Weighted Average and Diluted) advanced to $0.41 in Q2 2026 per USNA's latest filing, from -$0.09 in the prior quarter.
• Over five years, EPS (Weighted Average and Diluted) peaked at $1.73 in Q1 2022 and troughed at -$0.36 in Q3 2025.
• A 5-year average of $0.65 and a median of $0.62 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
• The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) soared 31.82% in 2023, then slumped 164.29% in 2025.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.66 in 2022, then soared by 31.82% to $0.87 in 2023, then sank by 73.56% to $0.23 in 2024, then slumped by 256.52% to -$0.36 in 2025, then soared by 213.89% to $0.41 in 2026.
• Business Quant data shows USNA's EPS (Weighted Average and Diluted) at $0.41 in Q2 2026, -$0.09 in Q1 2026, and -$0.36 in Q3 2025.